Van Broeckhoven C, Genthe A M, Vandenberghe A, Horsthemke B, Backhovens H, Raeymaekers P, Van Hul W, Wehnert A, Gheuens J, Cras P
Nature. 1987;329(6135):153-5. doi: 10.1038/329153a0.
The gene coding for the amyloid protein, a component of neuritic plaques found in brain tissue from patients with Alzheimer's disease, has been localized to chromosome 21, and neighbouring polymorphic DNA markers segregate with Alzheimer's disease in several large families. These data, and the association of Alzheimer's disease with Down's syndrome, suggest that overproduction of the amyloid protein, or production of an abnormal variant of the protein, may be the underlying pathological change causing Alzheimer's disease. We have identified a restriction fragment length polymorphism of the A4-amyloid gene, and find recombinants in two Alzheimer's disease families between Alzheimer's disease and the A4-amyloid locus. This demonstrates that the gene for plaque core A4-amyloid cannot be the locus of a defect causing Alzheimer's disease in these families. These data indicate that alterations in the plaque core amyloid gene cannot explain the molecular pathology for all cases of Alzheimer's disease.
编码淀粉样蛋白的基因,是在阿尔茨海默病患者脑组织中发现的神经炎性斑块的一个组成部分,已被定位到21号染色体,并且在几个大家族中,相邻的多态性DNA标记与阿尔茨海默病共分离。这些数据,以及阿尔茨海默病与唐氏综合征的关联,表明淀粉样蛋白的过量产生,或该蛋白异常变体的产生,可能是导致阿尔茨海默病的潜在病理变化。我们已经鉴定出A4淀粉样蛋白基因的一种限制性片段长度多态性,并在两个阿尔茨海默病家族中发现了阿尔茨海默病与A4淀粉样蛋白位点之间的重组体。这表明,斑块核心A4淀粉样蛋白的基因不可能是这些家族中导致阿尔茨海默病的缺陷位点。这些数据表明,斑块核心淀粉样蛋白基因的改变不能解释所有阿尔茨海默病病例的分子病理学。